Cargando…

The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors

BACKGROUND: Inter-individual differences in response to immune checkpoint inhibitors (ICI) remain a major challenge in cancer treatment. The composition of the gut microbiome has been associated with differential ICI outcome, but the underlying molecular mechanisms remain unclear, and therapeutic mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joachim, Laura, Göttert, Sascha, Sax, Anna, Steiger, Katja, Neuhaus, Klaus, Heinrich, Paul, Fan, Kaiji, Orberg, Erik Thiele, Kleigrewe, Karin, Ruland, Jürgen, Bassermann, Florian, Herr, Wolfgang, Posch, Christian, Heidegger, Simon, Poeck, Hendrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597767/ https://www.ncbi.nlm.nih.gov/pubmed/37865045 http://dx.doi.org/10.1016/j.ebiom.2023.104834

Ejemplares similares

Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells
por: Fischer, Julius C., et al.
Publicado: (2019)

Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy
por: Heidegger, Simon, et al.
Publicado: (2023)

ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations
por: Hecker, Judith S., et al.
Publicado: (2021)

RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
por: Heidegger, Simon, et al.
Publicado: (2019)

Lactiplantibacillus pentoses CCFM1227 Produces Desaminotyrosine to Protect against Influenza Virus H1N1 Infection through the Type I Interferon in Mice
por: Wang, Qianwen, et al.
Publicado: (2023)

Card9 controls Dectin‐1‐induced T‐cell cytotoxicity and tumor growth in mice
por: Haas, Tobias, et al.
Publicado: (2017)

Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD
por: Jarosch, Sebastian, et al.
Publicado: (2023)

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation
por: Heidegger, Simon, et al.
Publicado: (2014)

Interleukin-17 and type 17 helper T cells in cancer management and research
por: Llosa, Nicolas J, et al.
Publicado: (2014)

HDAC Inhibition to Prime Immune Checkpoint Inhibitors
por: Borcoman, Edith, et al.
Publicado: (2021)

Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection
por: Albers, Julian J, et al.
Publicado: (2019)

Targeting RIG-I or STING promotes epithelial regeneration
por: Fischer, Julius C., et al.
Publicado: (2017)

Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
por: Bek, Sarah, et al.
Publicado: (2019)

Targeting the CBM complex causes Treg cells to prime tumors for immune checkpoint therapy
por: Pilato, Mauro Di, et al.
Publicado: (2019)

Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
por: Lu, Chia-Sing, et al.
Publicado: (2020)

Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
por: Ritter, Cathrin, et al.
Publicado: (2017)

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2021)

Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells
por: Sabins, Nina C., et al.
Publicado: (2016)

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity
por: Hammond, Sean, et al.
Publicado: (2021)

Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection
por: Kosinska, Anna D., et al.
Publicado: (2019)

Prime-boost using Separate Oncolytic Viruses in Combination with Checkpoint Blockade Improves Anti-tumor Therapy
por: Ilett, Elizabeth, et al.
Publicado: (2016)

Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy
por: Mantilla-Rojas, Carolina, et al.
Publicado: (2022)

Circulating Tumor DNA Profiling of a Diffuse Large B Cell Lymphoma Patient with Secondary Acute Myeloid Leukemia
por: Kerle, Irina A., et al.
Publicado: (2022)

Priming effects in reading words with vertically and horizontally mirrored letters
por: Pittrich, Katharina, et al.
Publicado: (2023)

Going Wild in the City—Animal Feralization and Its Impacts on Biodiversity in Urban Environments
por: Göttert, Thomas, et al.
Publicado: (2023)

Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis
por: Lengfelder, Isabella, et al.
Publicado: (2019)

Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
por: Klepsch, Victoria, et al.
Publicado: (2020)

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time?
por: Aras, Mandar A., et al.
Publicado: (2020)

Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade
por: Wang, Chensu, et al.
Publicado: (2021)

Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge
por: van der Westhuizen, Andre, et al.
Publicado: (2022)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

Protection of Antigen-Primed Effector T Cells From Glucocorticoid-Induced Apoptosis in Cell Culture and in a Mouse Model of Multiple Sclerosis
por: Bier, Jasmina, et al.
Publicado: (2021)

PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
por: Wartewig, Tim, et al.
Publicado: (2017)

Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer
por: Stump, Courtney T., et al.
Publicado: (2021)

Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming
por: Lobo, Catarina S., et al.
Publicado: (2023)

Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation
por: Ghimire, Sakhila, et al.
Publicado: (2022)

Waste Workers’ Exposure to Airborne Fungal and Bacterial Species in the Truck Cab and During Waste Collection
por: Madsen, Anne Mette, et al.
Publicado: (2016)

Spatial Behavior and Habitat Use of Two Sympatric Bat Species
por: Starik, Nicole, et al.
Publicado: (2021)

Use of Quantitative Mass Spectrometric Analysis to Elucidate the Mechanisms of Phospho-priming and Auto-activation of the Checkpoint Kinase Rad53 in Vivo
por: Chen, Eric S.-W., et al.
Publicado: (2014)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
por: McAuliffe, James, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8b1otjvcdncnskth0lt35brnrt